glp-1ozempicgenetics
Why Ozempic Fails 1 in 10 People
A Stanford and ETH Zurich study found about 10% of people carry PAM gene variants linked to GLP-1 resistance, which may reduce how effectively Ozempic lowers blood sugar.
Selena·
3 articles
A Stanford and ETH Zurich study found about 10% of people carry PAM gene variants linked to GLP-1 resistance, which may reduce how effectively Ozempic lowers blood sugar.
A tiny 12-amino-acid peptide called BRP may curb appetite like semaglutide, without the nausea or muscle loss. Stanford researchers used AI to find it.
GLP-1 drugs like Ozempic suppress appetite — but without careful macro tracking, you risk losing muscle alongside fat.